GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

Source: 
Fierce Pharma
snippet: 

In the face of "unprecedented" demand for its shingles vaccine, GlaxoSmithKline is doing everything it can to boost supply. But in spite of those effortsit shipped as much vaccine in the third quarter as it did in the first half of the yearGSK says the Shingrix shortage will persist into 2019.